Italia markets open in 4 hours 17 minutes

Dow Jones
39.671,04
-201,95(-0,51%)
Nasdaq
16.801,54
-31,08(-0,18%)
Nikkei 225
38.896,47
+279,37(+0,72%)
EUR/USD
1,0832
+0,0005(+0,04%)
Bitcoin EUR
64.127,45
-570,77(-0,88%)
CMC Crypto 200
1.512,88
-13,54(-0,89%)

NVCR Jan 2026 17.500 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

6,30

0,00

(0,00%)

In data: 04:18PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in